Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer
Published in: Breast Cancer 2/2001

01-04-2001 | Original Article

Immunohistochemical analysis on biological markers in ductal carcinomain situ of the breast

Authors: Hirotaka Iwase, Yoshiaki Ando, Shu Ichihara, Satoshi Toyoshima, Taka-aki Nakamura, Shoji Karamatsu, Yukashi Ito, Hiroko Yamashita, Tatsuya Toyama, Yoko Omoto, Yoshitaka Fujii, Shoushu Mitsuyama, Shunzo Kobayashi

Published in: Breast Cancer | Issue 2/2001

Login to get access
Metadata
Title
Immunohistochemical analysis on biological markers in ductal carcinomain situ of the breast
Authors
Hirotaka Iwase
Yoshiaki Ando
Shu Ichihara
Satoshi Toyoshima
Taka-aki Nakamura
Shoji Karamatsu
Yukashi Ito
Hiroko Yamashita
Tatsuya Toyama
Yoko Omoto
Yoshitaka Fujii
Shoushu Mitsuyama
Shunzo Kobayashi
Publication date
01-04-2001
Publisher
Springer-Verlag
Published in
Breast Cancer / Issue 2/2001
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/BF02967487

Other articles of this Issue 2/2001

Breast Cancer 2/2001 Go to the issue

Original Article

Evaluation of bone metabolic markers in breast cancer with bone metastasis

Case Report

Reconstruction of Breast Using A Laser Lithographic Model: A Case Report

Original Article

Correlation between nuclear grade and biological prognostic variables in invasive Breast Cancer

Original Article

Results of Breast-Conserving Therapy for Ductal Carcinomain situ: The Kyoto University Experiences

Original Article

Staging of palpable tl-2 invasive breast cancer with helical ct

Case Report

Two Cases of Cholesterol Granuloma of the Breast
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits